Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-036667
Filing Date
2022-06-14
Accepted
2022-06-14 16:15:23
Documents
1
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6345
  Complete submission text file 0001209191-22-036667.txt   7708
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIRIDIAN THERAPEUTICS, INC. 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address
Humer Kristian (Reporting) CIK: 0001872280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 221015037